VTGN
USDVistagen Therapeutics Inc. Common Stock
$4.070-0.110 (-2.632%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$4.180
High
$4.296
Low
$4.060
Volume
0.21M
Company Fundamentals
Market Cap
124.9M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.57M
Exchange
NCM
Currency
USD
52-Week Range
Low $1.9Current $4.070High $4.65
Related News
BusinessWire
Vistagen to Report Fiscal Year 2026 Second Quarter Results and Host Corporate Update Conference Call on November 13, 2025
Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called
View more
BusinessWire
Vistagen Completes PALISADE-3 Phase 3 Public Speaking Challenge Study for the Acute Treatment of Social Anxiety Disorder
Topline results for the trial are expected by year end Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.